Being ranked as the fastest-growing company on a prestigious list like the Deloitte Technology Fast 500™ is likely to boost investor confidence and attract positive attention to TG Therapeutics. This recognition suggests strong revenue growth and potential for continued success, which can positively impact the stock price in the short term.